UniProt ID | ANXA4_HUMAN | |
---|---|---|
UniProt AC | P09525 | |
Protein Name | Annexin A4 | |
Gene Name | ANXA4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 319 | |
Subcellular Localization | ||
Protein Description | Calcium/phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis.. | |
Protein Sequence | MATKGGTVKAASGFNAMEDAQTLRKAMKGLGTDEDAIISVLAYRNTAQRQEIRTAYKSTIGRDLIDDLKSELSGNFEQVIVGMMTPTVLYDVQELRRAMKGAGTDEGCLIEILASRTPEEIRRISQTYQQQYGRSLEDDIRSDTSFMFQRVLVSLSAGGRDEGNYLDDALVRQDAQDLYEAGEKKWGTDEVKFLTVLCSRNRNHLLHVFDEYKRISQKDIEQSIKSETSGSFEDALLAIVKCMRNKSAYFAEKLYKSMKGLGTDDNTLIRVMVSRAEIDMLDIRAHFKRLYGKSLYSFIKGDTSGDYRKVLLVLCGGDD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATKGGTVK ------CCCCCCCEE | 20.30 | 22814378 | |
7 | Phosphorylation | -MATKGGTVKAASGF -CCCCCCCEECCCCC | 27.74 | 28857561 | |
12 | Phosphorylation | GGTVKAASGFNAMED CCCEECCCCCCHHHH | 49.10 | 25159151 | |
14 | Phosphorylation | TVKAASGFNAMEDAQ CEECCCCCCHHHHHH | 4.96 | 20166139 | |
17 | Sulfoxidation | AASGFNAMEDAQTLR CCCCCCHHHHHHHHH | 5.13 | 21406390 | |
18 | Ubiquitination | ASGFNAMEDAQTLRK CCCCCHHHHHHHHHH | 48.02 | - | |
22 | Phosphorylation | NAMEDAQTLRKAMKG CHHHHHHHHHHHHCC | 30.19 | 46164693 | |
30 | Ubiquitination | LRKAMKGLGTDEDAI HHHHHCCCCCCHHHH | 5.79 | - | |
43 | Phosphorylation | AIISVLAYRNTAQRQ HHHHHHHHCCHHHHH | 10.55 | 27259358 | |
56 | Phosphorylation | RQEIRTAYKSTIGRD HHHHHHHHHHHHCHH | 12.59 | 23312004 | |
57 | Succinylation | QEIRTAYKSTIGRDL HHHHHHHHHHHCHHH | 38.36 | 23954790 | |
58 | Phosphorylation | EIRTAYKSTIGRDLI HHHHHHHHHHCHHHH | 16.75 | 23312004 | |
59 | Phosphorylation | IRTAYKSTIGRDLID HHHHHHHHHCHHHHH | 24.25 | 23312004 | |
59 | Ubiquitination | IRTAYKSTIGRDLID HHHHHHHHHCHHHHH | 24.25 | - | |
69 | Acetylation | RDLIDDLKSELSGNF HHHHHHHHHHHCCCH | 49.21 | - | |
71 | Sumoylation | LIDDLKSELSGNFEQ HHHHHHHHHCCCHHH | 45.42 | - | |
85 | Phosphorylation | QVIVGMMTPTVLYDV HHHHHCCCHHHHHCH | 13.60 | 26552605 | |
87 | Phosphorylation | IVGMMTPTVLYDVQE HHHCCCHHHHHCHHH | 17.61 | 26552605 | |
90 | Phosphorylation | MMTPTVLYDVQELRR CCCHHHHHCHHHHHH | 15.10 | 26552605 | |
100 | Acetylation | QELRRAMKGAGTDEG HHHHHHHCCCCCCCC | 44.62 | - | |
102 | Ubiquitination | LRRAMKGAGTDEGCL HHHHHCCCCCCCCHH | 16.52 | - | |
108 | S-nitrosylation | GAGTDEGCLIEILAS CCCCCCCHHHHHHHC | 3.05 | 25040305 | |
115 | Phosphorylation | CLIEILASRTPEEIR HHHHHHHCCCHHHHH | 32.99 | 28857561 | |
117 | Phosphorylation | IEILASRTPEEIRRI HHHHHCCCHHHHHHH | 32.34 | 28857561 | |
125 | Phosphorylation | PEEIRRISQTYQQQY HHHHHHHHHHHHHHH | 18.04 | 28152594 | |
127 | Phosphorylation | EIRRISQTYQQQYGR HHHHHHHHHHHHHCC | 19.26 | 24719451 | |
128 | Phosphorylation | IRRISQTYQQQYGRS HHHHHHHHHHHHCCC | 9.18 | 28152594 | |
130 | Phosphorylation | RISQTYQQQYGRSLE HHHHHHHHHHCCCHH | 28.22 | - | |
132 | Phosphorylation | SQTYQQQYGRSLEDD HHHHHHHHCCCHHHH | 15.35 | 28152594 | |
134 | Phosphorylation | TYQQQYGRSLEDDIR HHHHHHCCCHHHHHH | 32.89 | - | |
142 | Phosphorylation | SLEDDIRSDTSFMFQ CHHHHHHCCCHHHHH | 45.64 | 28857561 | |
144 | Phosphorylation | EDDIRSDTSFMFQRV HHHHHCCCHHHHHHH | 25.72 | 28857561 | |
147 | Sulfoxidation | IRSDTSFMFQRVLVS HHCCCHHHHHHHHHH | 2.54 | 21406390 | |
165 | Phosphorylation | GGRDEGNYLDDALVR CCCCCCCCCCHHHHH | 23.51 | 38513 | |
167 | Phosphorylation | RDEGNYLDDALVRQD CCCCCCCCHHHHHHC | 28.86 | - | |
179 | Phosphorylation | RQDAQDLYEAGEKKW HHCHHHHHHHHHHHC | 16.42 | 27362937 | |
181 | Phosphorylation | DAQDLYEAGEKKWGT CHHHHHHHHHHHCCC | 20.21 | - | |
184 | Ubiquitination | DLYEAGEKKWGTDEV HHHHHHHHHCCCCHH | 53.56 | 21890473 | |
186 | Ubiquitination | YEAGEKKWGTDEVKF HHHHHHHCCCCHHHH | 26.45 | - | |
187 | Ubiquitination | EAGEKKWGTDEVKFL HHHHHHCCCCHHHHH | 31.97 | - | |
199 | Phosphorylation | KFLTVLCSRNRNHLL HHHHHHHHCCCCCHH | 28.56 | 46164687 | |
211 | Ubiquitination | HLLHVFDEYKRISQK CHHHHHHHHHHCCHH | 41.30 | - | |
212 | Phosphorylation | LLHVFDEYKRISQKD HHHHHHHHHHCCHHH | 13.86 | 20560755 | |
213 | Acetylation | LHVFDEYKRISQKDI HHHHHHHHHCCHHHH | 41.00 | 19608861 | |
215 | Acetylation | VFDEYKRISQKDIEQ HHHHHHHCCHHHHHH | 4.47 | 19608861 | |
218 | Succinylation | EYKRISQKDIEQSIK HHHHCCHHHHHHHHH | 54.61 | 23954790 | |
218 | Acetylation | EYKRISQKDIEQSIK HHHHCCHHHHHHHHH | 54.61 | - | |
220 | Ubiquitination | KRISQKDIEQSIKSE HHCCHHHHHHHHHHC | 7.17 | - | |
223 | Phosphorylation | SQKDIEQSIKSETSG CHHHHHHHHHHCCCC | 21.13 | 28450419 | |
225 | Acetylation | KDIEQSIKSETSGSF HHHHHHHHHCCCCCH | 47.70 | 19608861 | |
226 | Phosphorylation | DIEQSIKSETSGSFE HHHHHHHHCCCCCHH | 44.42 | 28450419 | |
227 | Ubiquitination | IEQSIKSETSGSFED HHHHHHHCCCCCHHH | 41.83 | 19608861 | |
227 | Acetylation | IEQSIKSETSGSFED HHHHHHHCCCCCHHH | 41.83 | 19608861 | |
228 | Phosphorylation | EQSIKSETSGSFEDA HHHHHHCCCCCHHHH | 45.54 | 28450419 | |
229 | Phosphorylation | QSIKSETSGSFEDAL HHHHHCCCCCHHHHH | 28.52 | 28857561 | |
231 | Phosphorylation | IKSETSGSFEDALLA HHHCCCCCHHHHHHH | 25.82 | 27251275 | |
248 | Ubiquitination | KCMRNKSAYFAEKLY HHHHCCCHHHHHHHH | 12.69 | - | |
253 | Acetylation | KSAYFAEKLYKSMKG CCHHHHHHHHHHHCC | 54.40 | 25825284 | |
255 | Phosphorylation | AYFAEKLYKSMKGLG HHHHHHHHHHHCCCC | 16.46 | 6975611 | |
255 | Acetylation | AYFAEKLYKSMKGLG HHHHHHHHHHHCCCC | 16.46 | - | |
257 | Phosphorylation | FAEKLYKSMKGLGTD HHHHHHHHHCCCCCC | 16.51 | 22468782 | |
259 | Acetylation | EKLYKSMKGLGTDDN HHHHHHHCCCCCCCC | 59.06 | 7691955 | |
259 | Malonylation | EKLYKSMKGLGTDDN HHHHHHHCCCCCCCC | 59.06 | 26320211 | |
261 | Ubiquitination | LYKSMKGLGTDDNTL HHHHHCCCCCCCCHH | 5.79 | - | |
263 | Phosphorylation | KSMKGLGTDDNTLIR HHHCCCCCCCCHHHH | 45.26 | 18510355 | |
265 | Phosphorylation | MKGLGTDDNTLIRVM HCCCCCCCCHHHHHH | 50.26 | 18510355 | |
267 | Phosphorylation | GLGTDDNTLIRVMVS CCCCCCCHHHHHHHH | 30.47 | 23312004 | |
269 | Phosphorylation | GTDDNTLIRVMVSRA CCCCCHHHHHHHHHH | 2.69 | - | |
280 | Sulfoxidation | VSRAEIDMLDIRAHF HHHHHCCHHHHHHHH | 4.44 | 30846556 | |
293 | Ubiquitination | HFKRLYGKSLYSFIK HHHHHHCCHHHHHHH | 24.59 | 21890473 | |
293 | Acetylation | HFKRLYGKSLYSFIK HHHHHHCCHHHHHHH | 24.59 | 19608861 | |
293 | Ubiquitination | HFKRLYGKSLYSFIK HHHHHHCCHHHHHHH | 24.59 | 21890473 | |
294 | Phosphorylation | FKRLYGKSLYSFIKG HHHHHCCHHHHHHHC | 28.33 | 28152594 | |
295 | Ubiquitination | KRLYGKSLYSFIKGD HHHHCCHHHHHHHCC | 4.77 | 19608861 | |
295 | Acetylation | KRLYGKSLYSFIKGD HHHHCCHHHHHHHCC | 4.77 | 19608861 | |
296 | Phosphorylation | RLYGKSLYSFIKGDT HHHCCHHHHHHHCCC | 14.50 | 28152594 | |
297 | Phosphorylation | LYGKSLYSFIKGDTS HHCCHHHHHHHCCCC | 26.28 | 28152594 | |
298 | Phosphorylation | YGKSLYSFIKGDTSG HCCHHHHHHHCCCCC | 4.17 | - | |
299 | Phosphorylation | GKSLYSFIKGDTSGD CCHHHHHHHCCCCCC | 3.92 | 20068231 | |
300 | Malonylation | KSLYSFIKGDTSGDY CHHHHHHHCCCCCCC | 49.04 | 26320211 | |
300 | Acetylation | KSLYSFIKGDTSGDY CHHHHHHHCCCCCCC | 49.04 | 19608861 | |
302 | Acetylation | LYSFIKGDTSGDYRK HHHHHHCCCCCCCCE | 32.47 | 19608861 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ANXA4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ANXA4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ANXA4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NFKB1_HUMAN | NFKB1 | physical | 20237821 | |
ASM_HUMAN | SMPD1 | physical | 21900206 | |
NMT2_HUMAN | NMT2 | physical | 21900206 | |
DJB11_HUMAN | DNAJB11 | physical | 22939629 | |
ANXA7_HUMAN | ANXA7 | physical | 22939629 | |
THTM_HUMAN | MPST | physical | 22939629 | |
PADI4_HUMAN | PADI4 | physical | 25416956 | |
SF3A3_HUMAN | SF3A3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-213; LYS-225; LYS-293 ANDLYS-300, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-165, AND MASSSPECTROMETRY. |